Copyright Reports & Markets. All rights reserved.

Global Colorectal Cancer Therapeutics Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Colorectal Cancer Therapeutics Market Overview

      • 1.1 Product Overview and Scope of Colorectal Cancer Therapeutics
      • 1.2 Colorectal Cancer Therapeutics Segment by Type
        • 1.2.1 Global Colorectal Cancer Therapeutics Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Diagnostics
        • 1.2.3 Therapeutics
      • 1.3 Colorectal Cancer Therapeutics Segment by Application
        • 1.3.1 Colorectal Cancer Therapeutics Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinic
        • 1.3.4 Research institutions
      • 1.3 Global Colorectal Cancer Therapeutics Market by Region
        • 1.3.1 Global Colorectal Cancer Therapeutics Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Colorectal Cancer Therapeutics Market Size
        • 1.4.1 Global Colorectal Cancer Therapeutics Revenue (2014-2025)
        • 1.4.2 Global Colorectal Cancer Therapeutics Production (2014-2025)

      2 Global Colorectal Cancer Therapeutics Market Competition by Manufacturers

      • 2.1 Global Colorectal Cancer Therapeutics Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Colorectal Cancer Therapeutics Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Colorectal Cancer Therapeutics Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Colorectal Cancer Therapeutics Production Sites, Area Served, Product Types
      • 2.5 Colorectal Cancer Therapeutics Market Competitive Situation and Trends
        • 2.5.1 Colorectal Cancer Therapeutics Market Concentration Rate
        • 2.5.2 Colorectal Cancer Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Colorectal Cancer Therapeutics Production Market Share by Regions

      • 3.1 Global Colorectal Cancer Therapeutics Production Market Share by Regions
      • 3.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Colorectal Cancer Therapeutics Production
        • 3.4.1 North America Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.4.2 North America Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Colorectal Cancer Therapeutics Production
        • 3.5.1 Europe Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.5.2 Europe Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Colorectal Cancer Therapeutics Production (2014-2019)
        • 3.6.1 China Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.6.2 China Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Colorectal Cancer Therapeutics Production (2014-2019)
        • 3.7.1 Japan Colorectal Cancer Therapeutics Production Growth Rate (2014-2019)
        • 3.7.2 Japan Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Colorectal Cancer Therapeutics Consumption by Regions

      • 4.1 Global Colorectal Cancer Therapeutics Consumption by Regions
      • 4.2 North America Colorectal Cancer Therapeutics Consumption (2014-2019)
      • 4.3 Europe Colorectal Cancer Therapeutics Consumption (2014-2019)
      • 4.4 China Colorectal Cancer Therapeutics Consumption (2014-2019)
      • 4.5 Japan Colorectal Cancer Therapeutics Consumption (2014-2019)

      5 Global Colorectal Cancer Therapeutics Production, Revenue, Price Trend by Type

      • 5.1 Global Colorectal Cancer Therapeutics Production Market Share by Type (2014-2019)
      • 5.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2014-2019)
      • 5.3 Global Colorectal Cancer Therapeutics Price by Type (2014-2019)
      • 5.4 Global Colorectal Cancer Therapeutics Production Growth by Type (2014-2019)

      6 Global Colorectal Cancer Therapeutics Market Analysis by Applications

      • 6.1 Global Colorectal Cancer Therapeutics Consumption Market Share by Application (2014-2019)
      • 6.2 Global Colorectal Cancer Therapeutics Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Colorectal Cancer Therapeutics Business

      • 7.1 Taiho Pharma
        • 7.1.1 Taiho Pharma Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.1.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.1.3 Taiho Pharma Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Merck KGaA
        • 7.2.1 Merck KGaA Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.2.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.2.3 Merck KGaA Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Amgen
        • 7.3.1 Amgen Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.3.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.3.3 Amgen Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Takeda
        • 7.4.1 Takeda Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.4.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.4.3 Takeda Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Roche
        • 7.5.1 Roche Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.5.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.5.3 Roche Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Eli Lilly
        • 7.6.1 Eli Lilly Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.6.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.6.3 Eli Lilly Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Sanofi
        • 7.7.1 Sanofi Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.7.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.7.3 Sanofi Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Regeneron
        • 7.8.1 Regeneron Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.8.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.8.3 Regeneron Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Bayer
        • 7.9.1 Bayer Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.9.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.9.3 Bayer Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Onyx
        • 7.10.1 Onyx Colorectal Cancer Therapeutics Production Sites and Area Served
        • 7.10.2 Colorectal Cancer Therapeutics Product Introduction, Application and Specification
        • 7.10.3 Onyx Colorectal Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Bristol-Myers Squib
      • 7.12 Sumitomo Dainippon Pharma
      • 7.13 Array BioPharma
      • 7.14 Hutchison MediPharma
      • 7.15 Jiangsu Hengrui Medicine
      • 7.16 Jiangsu Chia-Tai Tianqing
      • 7.17 Suzhou Zelgen Biopharmaceuticals

      8 Colorectal Cancer Therapeutics Manufacturing Cost Analysis

      • 8.1 Colorectal Cancer Therapeutics Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Colorectal Cancer Therapeutics
      • 8.4 Colorectal Cancer Therapeutics Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Colorectal Cancer Therapeutics Distributors List
      • 9.3 Colorectal Cancer Therapeutics Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Colorectal Cancer Therapeutics Market Forecast

      • 11.1 Global Colorectal Cancer Therapeutics Production, Revenue Forecast
        • 11.1.1 Global Colorectal Cancer Therapeutics Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Colorectal Cancer Therapeutics Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Colorectal Cancer Therapeutics Price and Trend Forecast (2019-2025)
      • 11.2 Global Colorectal Cancer Therapeutics Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Colorectal Cancer Therapeutics Production, Revenue Forecast (2019-2025)
      • 11.3 Global Colorectal Cancer Therapeutics Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
        • 11.3.2 Europe Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
        • 11.3.3 China Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
        • 11.3.4 Japan Colorectal Cancer Therapeutics Consumption Forecast (2019-2025)
      • 11.4 Global Colorectal Cancer Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Colorectal Cancer Therapeutics Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

        The global Colorectal Cancer Therapeutics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Colorectal Cancer Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Colorectal Cancer Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Taiho Pharma
        Merck KGaA
        Amgen
        Takeda
        Roche
        Eli Lilly
        Sanofi
        Regeneron
        Bayer
        Onyx
        Bristol-Myers Squib
        Sumitomo Dainippon Pharma
        Array BioPharma
        Hutchison MediPharma
        Jiangsu Hengrui Medicine
        Jiangsu Chia-Tai Tianqing
        Suzhou Zelgen Biopharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Diagnostics
        Therapeutics

        Segment by Application
        Hospitals
        Clinic
        Research institutions

        Buy now